Screening for Malnutrition in Obese Patients
Recruiting · NCT06626360 · Observational (researchers observe without assigning treatment) · Lead sponsor: HAN University of Applied Sciences
View the official record on ClinicalTrials.gov →What this trial is about
More than half of the Dutch population is overweight or obese, which is associated with an increased risk of COVID-19 and worse outcomes during a COVID-19 infection. In addition, malnutrition and loss of muscle mass are often reported with COVID-19, as well as with cancer and other diseases. Malnutrition and overweight or obesity can coexist, even within the same individual. It is still unclear which mechanisms contribute to the worse outcomes of COVID-19 and other diseases in case of overweight, malnutrition, and a combination of both. The aim of this study is to identify which parameters are associated with worse disease outcomes through literature research and database research (COVID-19 and cancer, more than 150.000 participants). In addition, a clinical study will be conducted aiming to develop a simple screening tool for the recognition of the coexistence of malnutrition and overweight or obesity in clinical practice.
Who can take part
Inclusion criteria
- Age 18 years or older
- Overweight (BMI of 25 kg/m² or higher)
Exclusion criteria
- Physically or mentally unable to participate.
- Severe cognitive disorder or severe emotional instability, as assessed by the attending nurse or physician.
- Insufficient proficiency in the Dutch language to express themselves properly and no interpreter or assistant to help.
- Patient resides in a nursing or care home.
Where it is running
3 locations listed.
- OLVG - Amsterdam, Netherlands
- Ziekenhuis Gelderse Vallei - Ede, Netherlands
- ErasmusMC - Rotterdam, Netherlands